Influence of early season moxidectin treatments on acquisition of immunity to Ostertagia ostertagi in calves.

Moxidectin, a newly developed endectocide, has previously been demonstrated to have a high efficacy against gastrointestinal nematodes in cattle ( 1992, 1992). In a field trial ( and Nansen, unpublished data) matched groups of 8 first-season Black Pied Friesian heifer calves, 6-8 months of age, were turned out in early May 1992 on a permanent pasture contaminated with trichostrongyles. The groups were grazed separately on comparable plots until they were housed in mid October 1992. Group Β was treated with moxidectin at turnout, and group C was treated at turnout and again 8 weeks after turnout. A third group served as non-treated controls (group A). The results showed that the 2 early season prophylactic treatments (group C) reduced the late season herbage trichostrongyle larval infectivity with 80 to 90%, whereas the reduction accomplished by only 1 treatment at turnout (group B) was much less. Group C excreted significantly lower numbers of strongyle eggs than groups A and B. The non-treated controls showed clinical signs of trichostrongylosis in late September, which coincided with a steep rise in serum pepsinogen levels reaching an average peak level of 3.5 IU tyrosine litre-1. A few animals in group Β showed softening of faeces particularly in the very late season. In contrast, animals receiving 2 moxidectin treatments remained in a clinically good condition throughout the season.